PharmExec Direct Marketing Edition - Pharmaceutical Executive

ADVERTISEMENT

PharmExec Direct Marketing Edition

GSK Chooses MediaCom for a Billion-Dollar Planner Contract

December 18, 2007

GlaxoSmithKline locks up MediaCom as its only ad-buying/planning provider. The agency will handle GSK's massive ad spend, which last year hovered around $1.1 billion.

Vertex Pharmaceuticals Brings Transparency Online

December 18, 2007

Drug manufacturer shakes things up with new Web site that functions as an open book into the world of Vertex Pharmaceuticals. The company hopes that its transparent approach to design will be a lesson to pharma companies still fearful of online media.

Arkansas Attorney General Takes J&J to Task

December 5, 2007

The State of Arkansas filed suit against Risperdal manufacturer Johnson & Johnson, claiming promotion of the drug for nonmedical uses has led to increased prescriptions being written and bigger payouts by Medicaid.

In Defense of Peer Review: Waxman Opponents Argue for Distribution of Off-Label Info

December 5, 2007

Peer-review advocates speak out against Congressman Waxman?s stance on a new policy that would allow pharma to distribute unbiased journal articles to doctors without prior approval.

Doc-Driven Search Site Lists Top Search Terms

November 21, 2007

A physician-oriented search engine reveals its most-searched terms. Among the winners: breast and lung cancer, cortisol, and HbA1c/glycated hemoglobin. Nowhere to be seen: pharmaceutical products.

Discovery Health Documentary Spotlights Diabetes and Offers a CME Credit

November 21, 2007

A new pharma-sponsored documentary chronicles one doctor?s adventure around the world as she searches for stories about living with diabetes. The program, sponsored by Novo Nordisk, enlightens viewers and offers physicians a chance to earn one AMA-approved CME credit.

GSK Told to Update Avandia Warnings

November 21, 2007

Faced with contradictory data about the safety of the diabetes treatment, FDA asks for a black-box warning and additional trials. But how much damage will the black box do?

Lilly's New Blood Thinner No Blockbuster

November 6, 2007

Safety Risks, Generic Threat Scale Down Big Hopes

Stormy Forecast for Pharma in 2008

November 6, 2007

Bright Spots Are Emerging Markets, Specialty Drugs, Says IMS Health

ADVERTISEMENT

Click here